RUTESPI Trademark

Trademark Overview


On Tuesday, February 14, 2023, a trademark application was filed for RUTESPI with the United States Patent and Trademark Office. The USPTO has given the RUTESPI trademark a serial number of 97793808. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 5, 2024. This trademark is owned by Glaxo Group Limited. The RUTESPI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
rutespi

General Information


Serial Number97793808
Word MarkRUTESPI
Filing DateTuesday, February 14, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Friday, February 17, 2023NEW APPLICATION ENTERED
Friday, March 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Monday, November 13, 2023NON-FINAL ACTION WRITTEN
Monday, November 13, 2023NON-FINAL ACTION E-MAILED
Monday, November 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 4, 2024TEAS DELETE 1(B) BASIS RECEIVED